MoneyWorks4Me

Dr Reddys Laboratories’ Q2 consolidated net slumps 60%

25 Oct 2016 Evaluate

Dr Reddys Laboratories has reported results for second quarter ended September 30, 2016.

The company has reported 54.12% fall in its net profit at Rs 313.20 crore for the quarter under review as compared to Rs 682.60 crore for the same quarter in the previous year. Total income of the company decreased by 9.68% at Rs 2691.40 crore for Q2FY17 as compared Rs 2980.00 crore for the corresponding quarter previous year. 

On the consolidated basis, the company has reported 60.13% fall in its net profit after tax, minority interest and share of profit of associates at Rs 308.90 crore for the quarter ended September 30, 2016 as compared to Rs 774.70 crore for the same quarter in the previous year. The total income of the company decreased by 10.58% at Rs 3660.10 crore for quarter under review as compared to Rs 4093.10 crore for the quarter ended September 30, 2015. 

 

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..